Skip to main content
SpringerLink
Log in

Why the Sexual Tipping Point® Is a “Variable Switch Model”

  • Invited Commentary
  • Published:
Current Sexual Health Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Data availability

All variations of the STP schematics and additional information regarding the STP model are available for viewing and free downloading at mapedfund.org.

References

  1. Perelman MA. The sexual tipping point: a mind/body model for sexual medicine. J Sex Med United States. 2009;6:227–632.

    Google Scholar 

  2. Perelman MA. Why the Sexual Tipping Point® Model? Curr Sex Health Rep Springer US. 2016;8:39–46.

    Article  Google Scholar 

  3. Rosenfield P. The potential of transdisciplinary research for sustaining and extending linkages between the health and social sciences. Soc Sci Med. 2002:1–15.

  4. Abdo CHN, Afif-Abdo J, Otani F, Machado AC. Sexual satisfaction among patients with erectile dysfunction treated with counseling, sildenafil, or both. J Sex Med. 2008;5:1720–6.

    Article  PubMed  Google Scholar 

  5. Althof SE. Sexual therapy in the age of pharmacotherapy. Annu Rev Sex Res. 2006;17:116–31.

    Google Scholar 

  6. Perelman MA. The history of sexual medicine. In: APA handbook of sexuality and psychology, Vol. 2: contextual approaches. Washington: American Psychological Association; 2014. p. 137–79.

    Chapter  Google Scholar 

  7. Perelman MA. Integrated sex therapy: a psychosocial-cultural perspective integrating behavioral, cognitive, and medical approaches. In: Carson CC, Kirby RS, Wyllie MG, editors. Textbook of erectile dysfunction. 2nd ed. London: Informa Healthcare; 2009. p. 298–305.

    Google Scholar 

  8. Perelman MA. Psychosocial evaluation and combination treatment of men with erectile dysfunction. Urol Clin North Am. 2005 ed. 2005;32:431–45–vi.

    Article  PubMed  Google Scholar 

  9. Phelps JS, Jain A, Monga M. The PsychoedPlusMed approach to erectile dysfunction treatment: the impact of combining a psychoeducational intervention with sildenafil. J Sex Marital Ther 2005 ed. 2004;30:305–14.

    Article  PubMed  Google Scholar 

  10. Rosen RC. Medical and psychological interventions for erectile dysfunction: toward a combined treatment approach. In: Leiblum S, Rosen RC, editors. Principles and practice of sex therapy. 3rd ed. New York: Guilford Press; 2000. p. 276–304.

    Google Scholar 

  11. Kaplan HS. The sexual desire disorders: dysfunctional regulation of sexual motivation. New York: Brunner/Mazel, Inc; 1995.

    Google Scholar 

  12. Bancroft J, Graham CA, Janssen E, Sanders SA. The dual control model: current status and future directions. J Sex Res. 2009;42:121–42. [Internet]. 2009 ed. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19308839

    Article  Google Scholar 

  13. Bloemers J, van Rooij K, Poels S, Goldstein I, Everaerd W, Koppeschaar H, et al. Toward personalized sexual medicine (part 1): integrating the “dual control model” into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder. J Sex Med. 2012;10:791–809.

    Article  PubMed  Google Scholar 

  14. Perelman MA. Helen Singer Kaplan’s legacy and the future of sexual medicine. J Sex Med. 2012;9:138.

    Google Scholar 

  15. Bancroft J. Central inhibition of sexual response in the male: a theoretical perspective. Neurosci Biobehav Rev. 1999;23:763–84.

    Article  CAS  PubMed  Google Scholar 

  16. Janssen E, Bankroft J. The dual control model of male sexual response: a theoretical approach to centrally mediated erectile dysfunction. Neurosci Biobehav Rev [Internet]. 2000;24:571–9. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10880822

    Article  Google Scholar 

  17. Bancroft J, Herbenick D, Barnes T, Hallam-Jones R, Wylie KR, Janssen E. The relevance of the dual control model to male sexual dysfunction: the Kinsey Institute/BASRT collaborative project. Sex Relation Ther. 2005;20:13–30.

    Article  Google Scholar 

  18. Janssen E, Bancroft J. The dual control model: the role of sexual inhibition and excitation in sexual arousal and behavior. Bloomington: Indiana University Press; 2007.

    Google Scholar 

  19. Janssen E, Vorst H, Finn P, Bancroft J. The sexual inhibition (SIS) and sexual excitation (SES) scales: I. Measuring sexual inhibition and excitation proneness in men. J Sex Res. 2002;39:114–26.

    Article  PubMed  Google Scholar 

  20. Kupferman I. Hypothalamus and limbic system motivation. In: Kandel ER, Schwartz JH, Jessell TM, editors. Principle of neural science. 3rd ed. New York: Elsevier; 1991.

    Google Scholar 

  21. Stahl SM, Allers KA, Sommer B. Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder. J Sex Med United States. 2011;8:15–27.

    Article  CAS  Google Scholar 

  22. Arnow BA, Millheiser L, Garrett A, Polan ML, Glover GH, Hill KR, et al. Women with hypoactive sexual desire disorder compared to normal females: a functional magnetic resonance imaging study. NSC IBRO. 2009;158:484–502.

    CAS  Google Scholar 

  23. Pfaus JG. Pathways of sexual desire. J Sex Med United States. 2009;6:1506–33.

    Article  CAS  Google Scholar 

  24. Perelman MA. Introduction: advocating for a transdisciplinary approach to the management of sexual disorders. In: Lipshultz LI, Pastuszak AW, Giraldi A, Goldstein AT, Perelman MA, editors. Management of sexual dysfunction in men and women. New York: Springer; 2016. p. 1–8.

    Google Scholar 

  25. Isaacson W. The innovators: how a group of hackers, geniuses, and geeks created the digital revolution. New York: Simon & Schuster; 2014.

    Google Scholar 

  26. Bevelin P. All I want to know is where I’m going to die so I’ll never go there. Marceline: Walsworth Publishing Company; 2016.

    Google Scholar 

  27. Harvard University. DNA nanoswitches reveal how life’s molecules connect. [Internet]. phys.org. 2015 [cited 2018 Feb 21]. p. 1–4. Available from: https://phys.org/news/2015-01-dna-nanoswitches-reveal-life-molecules.html.

  28. Bing S. Immortal life: a soon to be told true story. New York: Simon & Schuster; 2017.

    Google Scholar 

Download references

Acknowledgements

Alexander Pastuszak, MD, Ph.D., Barry McCarthy, Ph.D., and Sharon Parish, MD, are acknowledged for their helpful comments on earlier drafts of this commentary.

Author information

Authors and Affiliations

  1. Departments of Psychiatry, Reproductive Medicine & Urology, Weill Cornell Medicine, New York-Presbyterian, New York, NY, USA

    Michael A. Perelman

  2. MAP Education & Research Foundation, 70 East 77th Street, Suite 1C, New York, NY, 10075, USA

    Michael A. Perelman

Authors
  1. Michael A. Perelman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael A. Perelman.

Ethics declarations

Conflict of Interest

Michael A. Perelman reports is the Founder and Chairman of the MAP Education and Research Foundation that owns the registered trademark: The Sexual Tipping Point®.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Perelman, M.A. Why the Sexual Tipping Point® Is a “Variable Switch Model”. Curr Sex Health Rep 10, 38–43 (2018). https://doi.org/10.1007/s11930-018-0148-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11930-018-0148-3

Keywords

Search

Navigation